Fennec Pharmaceuticals (FENC) Tops Q1 EPS by 48c

Fennec Pharmaceuticals (NASDAQ: FENC) reported Q1 EPS of $0.41, $0.48 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $25.4 million versus the consensus estimate of $10.09 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Schwab's May activity shows margin loans nearly double
• Independent Bank receives regulatory approval for HCB Financial acquisition